“In medical devices, we’re often not the technology drivers as much as the technology recipients.”
When people think about medical device innovation, they often picture breakthroughs emerging in hospitals, research labs, or at healthcare companies. In reality, many of the technologies shaping modern medicine originated elsewhere.
From batteries and wireless communication to miniaturized electronics and advanced computing, medical devices are often built upon innovations first developed for entirely different industries.
As medical technology continues to evolve, staying connected to those broader advancements may be just as important as the work happening within healthcare itself.
The Technologies Behind the Technologies
Many of the technologies used in today’s medical devices aren’t entirely new. Instead, they are being revisited, refined, and applied in new ways.
The smartphone in your pocket offers a useful example. Decades of investment in batteries, semiconductors, wireless connectivity, sensors, and miniaturization have transformed consumer electronics. Those same advances continue to influence technologies ranging from wearable health monitors to implantable medical devices.
According to Cadence Neuroscience CEO Kent Leyde:
“In medical devices, we’re often not the technology drivers as much as the technology recipients. We didn’t invent the transistor, but we sure use a lot of them. And Moore’s law wasn’t built in our field, but it applies to us. The cell phone revolution and all of the packaging and integration and making things small, and the advancements in batteries that are now impacting all of our implantable devices–all of these things, we’re the recipients of.”
Rather than operating independently, healthcare innovation often builds upon breakthroughs that occur across electronics, computing, materials science, manufacturing, and communications.
Why Cross-Industry Innovation Matters
Medical devices have unique requirements. Systems must operate reliably, often for years, while meeting rigorous safety, quality, and regulatory standards.
Advances in adjacent industries can help address these challenges.
Smaller electronics may reduce device size. Improvements in battery technology can support longer operation between charges. New materials may improve durability and performance. Increased computing power can enable more sophisticated analysis of physiological signals.
Many of these developments originate outside of healthcare, yet they can influence what becomes possible for future medical technologies.
The Importance of Staying Curious
For innovators, this reality creates an important mindset: progress often comes from looking beyond one’s own industry.
As Kent explains:
“That means we have to be students of what’s going on outside of medical devices. Because that’s where a lot of our materials science and electronic and other advancements are going to come from.”
Sometimes those connections are surprisingly direct. As Kent notes, “Packaging developed to help electronics survive in space also helps electronics survive in the human body.” Advances originally created for aerospace, consumer electronics, communications, and other industries can ultimately find applications in healthcare, influencing how medical technologies are designed and developed.
This perspective is increasingly relevant as technologies converge. The boundaries between healthcare, software, electronics, artificial intelligence, and advanced manufacturing continue to blur, creating new opportunities for collaboration and discovery.
Looking Forward
The future of medical technology will likely be shaped not only by advances in medicine but also by progress occurring across many fields of science and engineering.
Innovation rarely happens in isolation. More often, it emerges when ideas, technologies, and expertise from different disciplines come together to solve complex problems.
For organizations developing new medical technologies, remaining connected to the broader innovation ecosystem is crucial to driving progress.
The ideas discussed in this article were explored further during a recent panel featuring Cadence Neuroscience CEO Kent Leyde alongside leaders from Resonant Link Medical and neuroloop GmbH, hosted by Medical Alley.
Watch the discussion:
Cadence Neuroscience is developing investigational medical technologies that have not been approved or cleared by the U.S. Food and Drug Administration (FDA) or other health authorities. Any forward-looking statements reflect current expectations and are subject to risks and uncertainties. Actual results may differ materially. This information is for educational purposes only and does not constitute medical advice or investigational device promotion. Patients should consult qualified healthcare providers regarding diagnosis and treatment options.
Currently, these investigational technologies are only accessible through participation in a clinical trial. To learn more about these investigational technologies and how to access them, talk with your qualified healthcare provider or visit www.clinicaltrials.gov.